Аβ-пептид является основным компонентом амилоидных бляшек, вызывающих нейротоксический эффект при болезни Альцгеймера. Мы сконструировали дрожжевой штамм, содержащий плазмиду с гибридным геном Аβ−SUP35MC на фоне делеции хромосомной копии генаSUP35. Полученные данные свидетельствуют о том, что гибридный белок Аβ-Sup35MC является дрожжевым прионом.


Ol'ga Evgen'evna Tsaponina

Artem Gennadievich Lada


Aleksandr Anatol'evich Rubel'


Viktoriya Vladimirovna Navolotskaya

Irina Tomosovna Petrova

Sergey Georgievich Inge-Vechtomov


Aleksey Petrovich Galkin


  1. Захаров И.А., Кожин С.А., Кожина Т.Н., Федорова И.В. Сборник методик по генетике дрожжей-сахаромицетов. -Л.: Наука, 1984. -143 с.
  2. Инге-Вечтомов С.Г. Идентификация некоторых групп сцепления у Петергофских генетических линий дрожжей//Генетика.-1971.-Т. 7. -C. 113-124.
  3. Borchsenius A.S., Wegrzyn R.D., Newnam G.P., et al. Yeast prion protein derivative defective in aggregate shearing and production of new «seeds»//EMBO J.-2001.-Vol. 20, N 23. -P. 6683-6691.
  4. Cai X.D., Golde T.E., Younkin S.G. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor//Science.-1993.-Vol. 259, N 5094.-P. 514-516.
  5. Citron M. Alzheimer's disease: treatments in discovery and development//Nat. Neurosci. -2002. -Suppl. -P. 1055-1057.
  6. Chernoff Y.O., Derkatch I.L., Inge-Vechtomov S.G. Multicopy Sup35 gene induces de novo appearance of psi-like factors in yeast Saccharomyces cerevisiae//Curr. Genet. -1993.-Vol. 24.-P. 268-270.
  7. Chernoff Y.O., Lindquist S.L., Ono B., Inge-Vechtomov S.G., Liebman S.W. Role of the chaperone HSP104 in prppagation of the yeast prion-like factor [PSI+]//Science. -1995.-Vol. 268.-P. 880-884.
  8. Chernoff Y.O., Galkin A.P., Lewitin E., Chernova T.A., Newnam G.P., Belenkiy S.M. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein//Mol. Microbiol.-2000.-Vol. 35, N 4. -P. 865-876.
  9. Derkatch I.L., Bradley M.E., Zhou P., Chernoff Y.O., Liebman S.W. Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae//Genetics.-1997.-Vol. 147, N 2.-P. 507-519.
  10. Derkatch I.L., Bradley M.E., Hong J.Y., Liebman S.W. Prions affect the appearance of other prions: the story of [PIN+]//Cell.-2001.-Vol. 106, N 2.-P. 171-182.
  11. Doel S.M., McCready S.J., Nierras C.R., Cox B.S. The dominant PNM2-mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene//Genetics. -1994.-Vol. 137, N 3.-P. 659-670.
  12. Hughes S.R., Goyal S., Sun J.E., Gonzalez-DeWhitt P., Fortes M.A., Riedel N.G., Sahasrabudhe S.R. Two-hybrid system as a model to study the interaction of beta-amyloid peptide monomers//Proc. Natl. Acad. Sci. USA. -1996.-Vol. 93, N 5.-P. 2065-2070.
  13. Kryndushkin D.S., Smirnov V.N., Ter-Avanesyan M.D., Kushnirov V.V. Increased expression of Hsp40 chaperones, transcriptional factors, and ribosomal protein Rpp0 can cure yeast prions//J. Biol. Chem. -2002.-Vol. 277, N 26.-P. 23702-23708.
  14. Liu J.J., Sondheimer N., Lindquist S.L. Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]//Proc. Natl. Acad. Sci. USA.-2002.-Vol. 99.-P. 16446-16453.
  15. Maniatis T., Fritsch E.E., Sambrook J. Molecular cloning. A laboratory manual//Cold Spring Harbor Laboratory.-1982. -479 p.
  16. Moriyama H., Edskes H.K., Wickner R.B. [URE3] prion propagation in Saccharomyces cerevisiae: requirement for chaperone Hsp104 and curing by overexpressed chaperone Ydj1p//Mol. Cell Biol.-2000.-Vol. 20, N 23.-P. 8916-22.
  17. Olsson A., Csajbok L., Ost M., Hoglund K., Nylen K., Rosengren L., Nellgard B., Blennow K. Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury//J. Neurol. -2004.-Vol. 251, N 7.-P. 870-876.
  18. Parsell D.A., Sanchez Y., Stitzel J. D., Lindquist S. Hsp104 is a highly conserved protein with two essential nucleotide-binding sites//Nature. -1991.-Vol. 353.-P. 270-273.
  19. Price D.L. and Sisodia S.S. Mutant genes in familial Alzheimer's disease and transgenic models//Ann. Rev. Neurosci. -1998.-Vol. 21.-P. 479 -505.
  20. Prusiner S.B. Shattuck lecture -neurodegenerative deseases and prions//N. Eng. J. Med. -2001.-Vol. 344, N 20. -P. 1516-1526.
  21. Rose M.D., Winstone F., Hieter P. Methods in yeast genetics. -CSHL Press, 1990. -198 p.
  22. Sherman F., Fink G.R., Hinks J.B. Methods in Yeast Genetics//Cold Spring Harbor. -N.Y.: Cold Spring Harbor Lab. Press, 1986.
  23. Suzuki N., Cheung T.T., Cai X.D., Odaka A. et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants//Science.-1994.-Vol. 264.-P. 1336-1340.
  24. Tamaoka A., Odaka A., Ishibashi Y., Usami M. et al. APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brain//J. Biol. Chem. -1994.-Vol. 269, N 52.-P. 32721-32724.
  25. Ter-Avanesyan M.D., Dagkesamanskaya A.R., Kushnirov V.V., Smirnov V.N. The Sup35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [PSI+] in the yeast Saccharomyces cerevisiae//Genetics. -1994. -Vol. 137.-P. 671-676.
  26. Tuite M.F., Mundy C.R., Cox B.S. Agents that cause a high frequency of genetic change from [psi+] to [psi-] in Saccharomyces cerevisiae//Genetics. -1981.-Vol. 98, N 4.-P. 691-711.
  27. Wegrzyn R.D., Bapat K., Newman G.P., Zink A.D., Chernoff Y.O. Mechanisn of prion loss after Hsp104 inactivation in yeast//Mol. Cell Biol. -2001.-Vol. 21. -P. 4656-4669.
  28. Wickner R.B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae//Science. -1994.-Vol. 264, N 5158.-P. 566-569.
  29. Wisniewski T., Ghiso J., Frangione B. Bilology of Aβ amyloid in Alzheimers disease//Neurobiology of disease. -1997.-Vol. 4.-P. 313-328.
  30. Zhouravleva G., Frolova L., Le Goff X., Le Guellec R., Inge-Vechtomov S., Kisselev L., Philippe M. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3//EMBO J. -1995. -Vol. 14.-P. 4065-4072.


Abstract - 268

PDF (Russian) - 267



Copyright (c) 2005 Tsaponina O.E., Lada A.G., Rubel' A.A., Navolotskaya V.V., Petrova I.T., Inge-Vechtomov S.G., Galkin A.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies